The Foundation for Peripheral Neuropathy (FPN) welcomes Dr. David Bennett, MB, PhD, to the Foundation’s Scientific Advisory Board (SAB), effective November 2023. The SAB advises both the Board of Directors and staff of the Foundation on matters related to science and technology relevant to peripheral neuropathy and its research. About Dr. David Bennett Dr. David […]
Happy fall! With the changing of the seasons here in the Midwest, we’re looking forward to spending time outside in the cooler weather, enjoying slow-cooked meals, and curling up with a cozy read. PN can make it harder to enjoy this time of year, so we’ve put together some articles to help you find some daily […]
Introduction to Anti-MAG Neuropathy Anti-MAG neuropathy refers to a rare auto-immune associated cause of peripheral neuropathy (PN). In this case, the person’s own immune system (specifically, the IgM monoclonal antibodies) attack nerve cells required for a healthy peripheral nervous system – resulting in a slowly progressive and debilitating condition. Patients often experience loss of mobility, […]
Read More… from TREATING ANTI-MAG PN – A LOOK BACK AND WHAT MAY BE COMING
August is sure to be a HOT month – and we’re not just talking about the temperature outside! After the recent wins in our advocacy work and an exciting matching gift campaign that launched this month, the Foundation for Peripheral Neuropathy continues its third quarter of the year with promise and excitement. Thank you for continuing to be a […]
Importance of Peripheral Neuropathy: Since 2019, the Foundation for Peripheral Neuropathy has been actively engaged in a campaign to increase federal funding for peripheral neuropathy research. We had an extraordinary breakthrough in fiscal year 2021, when Congress included “peripheral neuropathy” as an eligible condition for research funding from the Department of Defense’s Peer Reviewed Medical Research […]
Read More… from Importance of Peripheral Neuropathy Recognized in Appropriations Act
On July 27, 2023, the Senate Committee on Appropriations approved by a large bipartisan vote the Senate version of the fiscal year 2024 Defense Appropriations Act. As it has in the three previous years (FY21-23), the Committee included “peripheral neuropathy” as an eligible condition for receiving research grants from the Department of Defense’s Peer Reviewed Medical […]
FPN had a successful meeting at the Peripheral Nerve Society in Copenhagen last month. Lindsay Colbert, Executive Director, met with countless existing and new experts in PN research and collaborated with other Patient Advocacy Groups in the field. More updates and research findings will be shared in our upcoming newsletters, so please keep opening our […]
As we near the mid-year point, we continue to push through to advance our mission. A special thank you to everyone who helped make Peripheral Neuropathy Awareness Week a success! Please review our summary report of our awareness campaign and continue to help us share important information about this condition and our organization’s work. […]